L’épisode le plus récent
5. Sanofi spin-off: bidding war over the future of Pharma Durée : 30:54
In this episode of M&A Talks Europe, we dive into the high-stakes battle between private equity giants for Sanofi’s consumer medicine division, Opella, ultimately won by American CD&R for €15.5 billion. We’ll explore how this deal fits into broader trends in both the pharmaceutical and private equity sectors, Sanofi’s shift to biopharma, and the political uproar in France over healthcare sovereignty because of sale of Doliprane, most popular medicine in France. Tune in to learn more about pharma and carve-out deals!
GUID : af952a85-ac03-4bdc-987f-e0f1f1bcb8d5
Date de publication : 15/10/2024 à 01:12:45
Description M&A Talks Europe dives into the world of mergers, acquisitions, takeovers and other deals across the European market. Each episode breaks down the most important deals, industry trends, and key players shaping the future of European business.
Get in touch: matalks.europe@gmail.com.
